Similar articles

• CARCINOGENIC ACTIVITY OF A NEW ANTITUMOR AGENT, N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213).

  KELLY MG, O'GARA RW, GADEKAR K, YANCEY ST, OLIVERIO VT. KELLY MG, et al. Cancer Chemother Rep. 1964 Jul;39:77-80. Cancer Chemother Rep. 1964. PMID: 14201279 No abstract available.
• N-ISOPROPYL-ALPHA-(2-METHYLHDRAZINO)-P-TOLUAMIDE HYDROCHLORIDE (NSC-77213) FOR TREATMENT OF CANCER PATIENTS.

  FALKSON G, DEVILLIERS PC, FALKSON HC. FALKSON G, et al. Cancer Chemother Rep. 1965 May;46:7-16. Cancer Chemother Rep. 1965. PMID: 14330645 No abstract available.
• SOME PHARMACOLOGIC PROPERTIES OF A NEW ANTITUMOR AGENT, N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213).

  OLIVERIO VT, DENHAM C, DEVITA VT, KELLY MG. OLIVERIO VT, et al. Cancer Chemother Rep. 1964 Nov;42:1-7. Cancer Chemother Rep. 1964. PMID: 14226125 No abstract available.
• Newer concepts in chemotherapy of cancer.

  Ansfield FJ, Mackman S, Ramirez G. Ansfield FJ, et al. Oncology. 1972;26(2):114-20. doi: 10.1159/000224662. Oncology. 1972. PMID: 4559039 Review. No abstract available.
• INTRA-ARTERIAL INFUSION EMPHASIZING TREATMENT OF MALIGNANT NEOPLASMS.

  LAWTON RL. LAWTON RL. N Y State J Med. 1965 Jul 1;65:1768-82. N Y State J Med. 1965. PMID: 14303677 Review. No abstract available.